Faster antibiotic testing to improve care for ICU infections
Part of Infections clinical trials.
This study tests whether getting antibiotic resistance test results faster (within 6 hours) helps doctors choose the right antibiotic sooner for ICU patients with bloodstream infections caused by certain bacteria. Faster, accurate treatment may lead to better outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are in the intensive care unit (ICU) and will likely stay there for at least the next day.
- You have a bloodstream infection caused by certain bacteria (like E. coli, Klebsiella, or Pseudomonas, but not all types).
- Your blood culture result was reported on a weekday before 11 a.m., and you are already receiving an antibiotic called a beta-lactam (like penicillin or cephalosporin).
- You or a family member can give consent to join the study, and you are covered by French health insurance.
- You are not pregnant or breastfeeding, and you are not already in another research study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial checks if a faster test to find the best antibiotic for a bloodstream infection can improve treatment and outcomes. If you have a confirmed bloodstream infection, you may be able to join.
This trial looks at whether a rapid molecular test can help doctors choose the right antibiotics faster for hospitalized patients. It aims to improve how antibiotics are used and reduce unnecessary side effects.
This trial tests a new rapid test that can quickly identify the cause of a severe infection (sepsis) in ICU patients. The goal is to see if faster results help doctors choose the right treatment sooner.
This study tests whether quickly identifying the exact bacteria causing your lung infection and using special computer models to choose the best antibiotic dose can improve your recovery in the ICU. It aims to make antibiotic treatment more personalized and effective.
This trial tests a rapid diagnostic method that identifies the bacteria in your blood more quickly than standard tests. If it works, doctors can pick the right antibiotic sooner.
This study tests different antibiotic combinations for severe infections caused by hard-to-treat Gram-negative bacteria (like Pseudomonas or Acinetobacter). The goal is to find the best treatment for bloodstream infections or pneumonia that started in the hospital.
Hear when a new Gram-negative Bacteremia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.